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The Rapid Onset of
Nitrate Tolerance*
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Organic nitrates such as isosorbide dinitrate have been the
mainstay in the medical treatment of angina pectoris. How-
ever. in the past decade the role of the organic nitrates for
the treatment of angina has undergone reevaluation because
it is clear that nitrate tolerance limits the usefulness of these
drugs.
Nitrate tolerance. In retrospect. nitrate tolerance should
have been recognized as a major limitation in the use of these
drugs because it was well documented (",'en before the turn
of the 20th century. In 1888 Stewart (I) , bserved that. after
6 months' treatment with glycerol trinitrate for hyperten-
sion, only a slight hypotensive effect could be obtained even
with a 100-fold increase in dosage. In 1898 nitrate tolerance
was described (2) in munitions workers who developed
immunity to nitrate headaches after a few days of exposure.
Experimental in vivo studies (3) in the 1920s and 1930s
documented tolerance to various organic nitrates in the dog
and rat. Moreover, in the experimental animal. tolerance
was found to develop rapidly even after a single exposure.
Despite this evidence, it was assumed that tolerance would
not occur clinically because in the experimental studies high
doses of nitrates were used to induce tolerance. The fact that
tolerance could and did occur with doses used to treat angina
pectoris was convincingly documented by Thadani et al. (4)
in 1980. They observed diminution of the hypotensive effect
and less prolongation in walking time when isosorbide
dinitrate was given 4 times daily for 1week to patients with
chronic stable angina. Attenuation of nitrate effect on the
walking time to angina can occur even after the first dose of
isosorbide dinitrate.
The present study. This effect of isosorbide dinitrate is
convincingly demonstrated by Bassan (5) in this issue of the
Journal. He observed a slight attenuation of nitrate effect
with the second dose of isosorbide dinitrate and a marked
diminution with the third dose. all given the same day.
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Moreover. the duration of the effect was <3 h after each
dose. Because there must be at least a 10 h nitrate-free
period each day to avoid sustained nitrate tolerance. only
three doses of nitrate should be given in a 24 h period (6).
From these data Bassan (5) concluded that "conventional
three times daily administration of isosorbide dinitrate re-
sults in a significantly increased anginal threshold during
probably no more than 6 h of a 24 h period." Because of this
short duration of efficacy combined with the progressive
attenuation of antianginal effect after the first dose of iso-
sorbide dinitrate. we question whether this class of drug is
being prescribed appropriately for the majority of patients
with angina pectoris.
Therapeutic implications. Physicians commonly attempt
to prevent angina by prescribing nitrates on a four times
daily basis or in the form of a nitroglycerin adhesive patch
worn continuously for 24 h. not realizing how rapidly toler-
ance can occur. A recently completed trial (7) of the efficacy
of transdermal nitroglycerin showed that an increase in
exercise tolerance was observed only 4 h after the nitroglyc-
erin patch was applied on the I st day of treatment when the
patches were changed every 24 h. Nevertheless. nitrates can
be beneficial in preventing angina. For example. a nitroglyc-
erin patch applied before bedtime and removed at 10 AM may
provide welcome relief for the patient troubled by nocturnal
angina. The nitrate-free interval between 10 AM and bedtime
should avoid sustained tolerance. The patient who has
angina predominantly after eating may well benefit by taking
isosorbide dinitrate three times daily to prevent postprandial
angina. However. it would be surprising if the patient with
nocturnal angina were to obtain any benefit from a three
times daily dosing schedule with the first dose in the morn-
mg.
Nitrate delivery systems that produce steady state levels
rapidly lead to the development of nitrate tolerance. These
include nitroglycerin ointment. nitroglycerin patches and
slow release nitroglycerin. as well as intravenously admin-
istered nitroglycerin (6). In addition. nitrate tolerance devel-
ops during the prolonged use of organic nitrates in patients
with chronic heart failure in a fashion similar to its develop-
ment in patients with angina pectoris (8).
Mechanism of nitrate tolerance, Because nitrates are safe
and effective for a relatively brief duration. research has
been directed to understanding the mechanism of the phe-
nomenon of nitrate tolerance and to overcoming this vexing
clinical problem. One hypothesis is that nitrate tolerance
results from depletion of sulfhydryl groups in vascular
smooth muscle due to continuous exposure to organic ni-
trates. This depletion may decrease the ability of nitrate
receptors to bind organic nitrates, thus preventing a series of
reactions that ultimately activate the enzyme guanylate
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cyclase to produce cyclic guanosine monophosphate
(cGMP), which relaxes vascular smooth muscle. Therefore.
it has been postulated (9) that if the sulfhydryl groups of the
nitrate receptors could be replenished, nitrate responsive-
ness would be restored. Indeed, it has been shown (10) that
the administration of the sulfhydryl-containing compound
N-acetylcysteine partially reverses nitrate tolerance. There-
fore, coadministration of a sulfhydryl donor might provide a
means of overcoming the development of attenuation of
nitrate effect, but this approach has recently been questioned
(II) because of the inability of N-acetylcysteine to restore
nitroglycerin responsiveness in tolerant epicardial arteries or
veins in vivo. Sodium nitroprusside and molsidomine do not
utilize the cysteine-dependent pathway required for organic
nitrate action. These agents may still induce a nitrate effect
even during tolerance to organic nitrates (7). At present the
clinician is best advised to be aware of the rapid appearance
of nitrate tolerance and to prescribe accordingly.
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